Spanish law

New Spanish patent law 24/2015 

Main changes introduced by the new law

Studies and clinical testing directed to obtain the market authorization in Spain or abroad do not infringe the patent rights. This includes preparing, obtaining and using of the relevant active ingredient.

→   Shift to a granting system with substantive examination and post-grant opposition, for all Spanish patent applications →   Obligation of first filing a European or PCT application at the SPTO, for inventions made in Spain →   Possibility of limiting the scope of protection after grant/opposition →   Utility models →   Priority right →   Patentability →   Non-prejudicial disclosures →   Employees’ inventions →   Supplementary Protection Certificates and their procedure →   Bolar Provision →   Official fees and renewals →   Rehabilitation and restoration of rights →   Nullity →   Protective letters →   Compulsory licenses →   Jurisdiction and procedural provisions

Recent tweets

ZBM recognised in the IAM European Patent Office (EPO) Patent rankings 2022 zbm-patents.eu/en/zbm-recogni… pic.twitter.com/3pQ8sdAsl9

About 4 days ago from ZBM Patents's Twitter via Twitter Web App

Main office

Rambla de Catalunya, 123

08008 Barcelona

T +34 933 426 472

Madrid

Avda. Pio XII, 92

Building A, Ground Floor 2

ES-28036 Madrid

T +34 911 593 175

Copenhagen

Symbion / Fruebjergvej 3

DK-2100 Copenhagen Ø

T +45 702 810 22